Search Orphan Drug Designations and Approvals
-
| Generic Name: | Neratinib maleate Tablets |
|---|---|
| Date Designated: | 03/25/2024 |
| Orphan Designation: | Treatment of HER2-Positive Gastroesophageal Cancer with Brain Metastases |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Convalife Pharmaceuticals Co., Ltd. Room 518, Building 21, No.1-28, Lane 588, Tianxiong Road, Pudong New District, Shanghai China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







